| Record ID | marc_columbia/Columbia-extract-20221130-008.mrc:456336046:1276 |
| Source | marc_columbia |
| Download Link | /show-records/marc_columbia/Columbia-extract-20221130-008.mrc:456336046:1276?format=raw |
LEADER: 01276cam a2200325 a 4500
001 3911897
005 20221027000426.0
008 840620s1984 sz b 000 0 eng d
020 $a3805538251
035 $a(OCoLC)10456657
035 $a(OCoLC)ocm10456657
035 $a(CStRLIN)NYCM84-B1699
035 $9ADG4153HS
035 $a(NNC)3911897
035 $a3911897
040 $aDNLM$cDNLM$dCStRLIN$dCtY$dNNC-M
100 1 $aWhite, David O.$0http://id.loc.gov/authorities/names/n85029378
245 10 $aAntiviral chemotherapy, interferons and vaccines /$cDavid O. White.
260 $aBasel ; New York :$bKarger,$c1984.
300 $avii, 111 pages ;$c25 cm.
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
490 1 $aMonographs in virology ;$vv. 16
504 $aBibliography: p. [87]-111.
650 2 $aAntiviral Agents$xtherapeutic use.$0https://id.nlm.nih.gov/mesh/D000998Q000627
650 2 $aInterferons.$0https://id.nlm.nih.gov/mesh/D007372
650 2 $aViral Vaccines.$0https://id.nlm.nih.gov/mesh/D014765
650 2 $aVirus Diseases$xprevention & control.$0https://id.nlm.nih.gov/mesh/D014777Q000517
830 0 $aMonographs in virology ;$vv. 16.$0http://id.loc.gov/authorities/names/n84705973
852 00 $boff,hsl$hRM411$iW58 1984